SCHEMBL4849980

SCHEMBL4849980

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3ccccc3F)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.42
KDM4E B2RXH2 2/20 0.42
SYK P43405 2/20 0.41
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
KDR P35968 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
MAOB P27338 2/20 0.37
ESR1 P03372 1/20 0.37
PTPN1 P18031 1/20 0.37
HRH1 P35367 1/20 0.37
MAOA P21397 1/20 0.37
MCHR1 Q99705 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849810 0.91 ABCB1 (0.43) SLC6A9KDM4ESYKBCHEACHE
SCHEMBL4849970 0.89 SYK (0.44) SLC6A9KDM4ESYKBCHEACHE
SCHEMBL4852900 0.89 SYK (0.44) SLC6A9KDM4ESYKBCHEACHE
SCHEMBL4846881 0.89 MAOB (0.48) KDM4EBCHEACHEALDH1A1SMN1; SMN2
SCHEMBL4853788 0.89 MEN1 (0.40) KDM4ESYKBCHEACHEALDH1A1
SCHEMBL4854072 0.89 KDR (0.41) KDM4ESYKKDRALDH1A1MAOB
SCHEMBL4847248 0.88 HTR7 (0.43) SLC6A9KDM4ESYKBCHEACHE
SCHEMBL4849710 0.88 SYK (0.42) SLC6A9KDM4ESYKBCHEACHE
SCHEMBL14280886 0.88 SYK (0.43) SLC6A9KDM4ESYKBCHEACHE
SCHEMBL4852423 0.88 SYK (0.43) SLC6A9KDM4ESYKBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed